You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR METHANTHELINE BROMIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for methantheline bromide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01429090 ↗ Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution Completed RIEMSER Arzneimittel GmbH Phase 1 1999-10-01 The primary objective of the study is: •To describe extent and rate of absorption of methantheline after single oral dose administration of Vagantin® coated tablets (Test) in comparison to a methantheline bromide solution (Reference) The secondary objectives of the study are: - To determine elimination the half-life of methantheline bromide - To describe the effects of Test and Reference on salivation, accommodation, pupil response, blood pressure and heart rate - to assess frequency and intensity of adverse drug reactions
NCT01429090 ↗ Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution Completed University Medicine Greifswald Phase 1 1999-10-01 The primary objective of the study is: •To describe extent and rate of absorption of methantheline after single oral dose administration of Vagantin® coated tablets (Test) in comparison to a methantheline bromide solution (Reference) The secondary objectives of the study are: - To determine elimination the half-life of methantheline bromide - To describe the effects of Test and Reference on salivation, accommodation, pupil response, blood pressure and heart rate - to assess frequency and intensity of adverse drug reactions
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for methantheline bromide

Condition Name

Condition Name for methantheline bromide
Intervention Trials
Neurogenic Bladder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for methantheline bromide
Intervention Trials
Urinary Bladder, Neurogenic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for methantheline bromide

Trials by Country

Trials by Country for methantheline bromide
Location Trials
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for methantheline bromide

Clinical Trial Phase

Clinical Trial Phase for methantheline bromide
Clinical Trial Phase Trials
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for methantheline bromide
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for methantheline bromide

Sponsor Name

Sponsor Name for methantheline bromide
Sponsor Trials
University Medicine Greifswald 1
RIEMSER Arzneimittel GmbH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for methantheline bromide
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.